Accessibility statement

Logibiotech is committed to making its website accessible, in compliance with Legislative Decree No. 106 of 10 August 2018, which transposed EU Directive 2016/2102 of the European Parliament and of the Council. This accessibility statement applies to: https://www.logibiotech.com/

Compliance status:

Partially compliant

This website is partially compliant with the requirements set out in Appendix A of the UNI CEI EN 301549:2018 standard (WCAG 2.1) and with the requirements of Annex A of Ministerial Decree of 5 July 2005 (WCAG 2.0), due to the cases of non-compliance listed below:

C.10.1.1.1 – In the informational PDFs, some non-text content does not have a text alternative;
C.10.1.3.2 – In some PDFs, the reading order is not meaningful;
C.10.1.4.3 – Some texts in the informational PDFs do not have adequate contrast;
C.10.2.4.6 – Some table headers do not have the correct tag.

Drafting of the accessibility statement

This statement was drafted on 19/09/2025.

The assessment was carried out by third parties through objective and subjective analyses (see Article 3, paragraph 1, of Commission Implementing Decision (EU) 2018/1523).

This statement was last reviewed on 25/09/2025, in accordance with the recommendation to periodically review (at least annually) the accuracy of the information contained in this accessibility statement

Feedback and contact information

If you wish to contact the owner of the website, please use the following email address: marketing@logibiotech.com

Sending reports to AgID

In the event of an unsatisfactory response or failure to respond, within thirty days, to the notification or request, the interested party can forward a report to AgID, via certified e-mail (PEC), to the following address: protocollo@pec.agid.gov.it

Information on the website

Date of publication: 16/05/2023
Usability tests were carried out:no
CMS used: WordPress